| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 7213 | 2008 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ... Movement disorders 26 (S3), S42-S80, 2011 | 1144 | 2011 |
| International Parkinson and movement disorder society evidence‐based medicine review: update on treatments for the motor symptoms of Parkinson's disease SH Fox, R Katzenschlager, SY Lim, B Barton, RMA De Bie, K Seppi, ... Movement Disorders 33 (8), 1248-1266, 2018 | 973 | 2018 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ... Movement Disorders 26 (S3), S2-S41, 2011 | 863 | 2011 |
| Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review K Seppi, K Ray Chaudhuri, M Coelho, SH Fox, R Katzenschlager, ... Movement Disorders 34 (2), 180-198, 2019 | 857 | 2019 |
| Prevalence of repetitive and reward-seeking behaviors in Parkinson disease V Voon, K Hassan, M Zurowski, M De Souza, T Thomsen, S Fox, AE Lang, ... Neurology 67 (7), 1254-1257, 2006 | 536 | 2006 |
| A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease C Zadikoff, SH Fox, DF Tang‐Wai, T Thomsen, RMA De Bie, P Wadia, ... Movement disorders 23 (2), 297-299, 2008 | 533 | 2008 |
| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 524 | 2015 |
| Medication-related impulse control and repetitive behaviors in Parkinson disease V Voon, SH Fox Archives of neurology 64 (8), 1089-1096, 2007 | 509 | 2007 |
| Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: a pilot study KA Sieradzan, SH Fox, M Hill, JPR Dick, AR Crossman, JM Brotchie Neurology 57 (11), 2108-2111, 2001 | 430 | 2001 |
| Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease V Voon, T Thomsen, JM Miyasaki, M de Souza, A Shafro, SH Fox, ... Archives of Neurology 64 (2), 212-216, 2007 | 416 | 2007 |
| Prospective prevalence of pathologic gambling and medication association in Parkinson disease V Voon, K Hassan, M Zurowski, S Duff-Canning, M De Souza, S Fox, ... Neurology 66 (11), 1750-1752, 2006 | 413 | 2006 |
| The pharmacology of L-DOPA-induced dyskinesia in Parkinson’s disease P Huot, TH Johnston, JB Koprich, SH Fox, JM Brotchie Pharmacological reviews 65 (1), 171-222, 2013 | 384 | 2013 |
| Clinical spectrum of levodopa‐induced complications CC Aquino, SH Fox Movement Disorders 30 (1), 80-89, 2015 | 357 | 2015 |
| Levodopa‐induced dyskinesia in Parkinson disease: current and evolving concepts AJ Espay, F Morgante, A Merola, A Fasano, L Marsili, SH Fox, E Bezard, ... Annals of Neurology 84 (6), 797-811, 2018 | 330 | 2018 |
| Small intestinal bacterial overgrowth in Parkinson's disease AH Tan, S Mahadeva, AM Thalha, PR Gibson, CK Kiew, CM Yeat, SW Ng, ... Parkinsonism & related disorders 20 (5), 535-540, 2014 | 315 | 2014 |
| Serotonin 2A receptors and visual hallucinations in Parkinson disease B Ballanger, AP Strafella, T van Eimeren, M Zurowski, PM Rusjan, ... Archives of neurology 67 (4), 416-421, 2010 | 299 | 2010 |
| Overview of the extranigral aspects of Parkinson disease SY Lim, SH Fox, AE Lang Archives of neurology 66 (2), 167-172, 2009 | 288 | 2009 |
| A role for endocannabinoids in the generation of parkinsonism and levodopa‐induced dyskinesia in MPTP‐lesioned non‐human primate models of Parkinson's disease M Van der Stelt, SH Fox, M Hill, AR Crossman, S Petrosino, V Di Marzo, ... The FASEB journal 19 (9), 1140-1142, 2005 | 236 | 2005 |
| Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial AHV Schapira, SH Fox, RA Hauser, J Jankovic, WH Jost, C Kenney, ... JAMA neurology 74 (2), 216-224, 2017 | 230 | 2017 |
